Practice Guideline
doi: 10.1093/annonc/mdq207.
Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Affiliations
- PMID: 20555058
- DOI: 10.1093/annonc/mdq207
Item in Clipboard
Practice Guideline
Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Ann Oncol.
2010 May.
Free article
No abstract available
Similar articles
-
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2010 May;21 Suppl 5:v116-9. doi: 10.1093/annonc/mdq189. Ann Oncol. 2010. PMID: 20555059 No abstract available.
-
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2012 Oct;23 Suppl 7:vii56-64. doi: 10.1093/annonc/mds226. Ann Oncol. 2012. PMID: 22997455 No abstract available.
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).Ann Oncol. 2005;16 Suppl 1:i28-9. doi: 10.1093/annonc/mdi821. Ann Oncol. 2005. PMID: 15888743 No abstract available.
-
Combined modality therapy for early stage operable and locally advanced potentially resectable non-small cell lung carcinoma.Cancer Treat Res. 2001;105:149-70. doi: 10.1007/978-1-4615-1589-0_6. Cancer Treat Res. 2001. PMID: 11224986 Review. No abstract available.
-
Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer.Ann Oncol. 2007 Jul;18 Suppl 9:ix150-5. doi: 10.1093/annonc/mdm311. Ann Oncol. 2007. PMID: 17631569 Review. No abstract available.
Cited by
-
Gene Expression Levels of the Prolyl Hydroxylase Domain Proteins PHD1 and PHD2 but Not PHD3 Are Decreased in Primary Tumours and Correlate with Poor Prognosis of Patients with Surgically Resected Non-Small-Cell Lung Cancer.Cancers (Basel). 2021 May 12;13(10):2309. doi: 10.3390/cancers13102309. Cancers (Basel). 2021. PMID: 34065840 Free PMC article.
-
Clinicopathological and computed tomography features associated with recurrence-free survival of patients with small-sized peripheral invasive lung adenocarcinoma after sublobectomy.Quant Imaging Med Surg. 2023 Dec 1;13(12):8144-8156. doi: 10.21037/qims-23-559. Epub 2023 Oct 16. Quant Imaging Med Surg. 2023. PMID: 38106273 Free PMC article.
-
Deep Learning with Multimodal Integration for Predicting Recurrence in Patients with Non-Small Cell Lung Cancer.Sensors (Basel). 2022 Aug 31;22(17):6594. doi: 10.3390/s22176594. Sensors (Basel). 2022. PMID: 36081053 Free PMC article.
-
PPA1 promotes NSCLC progression via a JNK- and TP53-dependent manner.Oncogenesis. 2019 Sep 24;8(10):53. doi: 10.1038/s41389-019-0162-y. Oncogenesis. 2019. PMID: 31551407 Free PMC article.
-
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung Cancer.J Thorac Oncol. 2018 Mar;13(3):426-435. doi: 10.1016/j.jtho.2017.11.135. Epub 2018 Jan 8. J Thorac Oncol. 2018. PMID: 29326090 Free PMC article.
